HVH Precision Analytics Named ‘Analytics Solution Provider Company of the Year’

Date: 07/12/2019

Pharma Tech Outlook Magazine Honors HVH for Its Work Providing Actionable Data-Driven Insights for Predictive Analytics

New York, NY, July 19, 2018

Today, Havas Health & You announced that HVH Precision Analytics (HVH), which provides advanced analytics and services utilizing real-world data to achieve actionable insights, has been named “Company of the Year” on Pharma Tech Outlook’s list of Top 10 Analytics Solution Providers in the pharmacy and life science field. The honor was determined by a panel of CEOs, CIOs, VCs and analysts, along with Pharma Tech Outlook’s editorial board.

HVH was built out of a unique partnership between Perspecta Inc. (formerly Vencore Inc), a leading U.S. government services provider, and Havas Health & You (part of Havas Group), a global communications company focused on health and wellness. ​Since it was founded in 2016, HVH has worked to shorten the time to diagnosis through the use of a proven and validated methodology to find diagnosed patients, prospective therapy candidates, undiagnosed patients and ideal candidates for clinical trials.

“This recognition is well-deserved by our cross-functional team of analysts and medical professionals,” said HVH CEO Steve Costalas. “By blending a machine-learning approach with analytics and medical expertise, we’re creating optimal outcomes for our customers and preserving a needed balance between finding exceptional p-values and making sure we aren’t biased by clinical expectations.”

HVH’s proprietary AI/machine learning and predictive analytics platform and methodology was developed more than 30 years ago and is now being used to solve complex problems for U.S. Intelligence Community agencies and sophisticated global healthcare clients. The HVH platform is data agnostic; it ingests, curates and analyzes vast amounts of disparate types of real-world data—including claims, electronic health records (EHR), laboratory, -omics, imagery and consumer data.

“We’re extremely proud to receive this honor and look forward to the important work that HVH will continue to do in the years to come,” said Donna Murphy, global CEO of Havas Health & You. “Our first-of-its-kind platform is making accelerated diagnoses possible for patients, which shows great promise in enhancing wellness and quality of life for those who otherwise may not seek treatment as quickly.”

“I also would like to congratulate the HVH team on this remarkable achievement,” said Mac Curtis, president and CEO of Perspecta. “Perspecta holds a leadership position in data analytics when it comes to helping government customers solve highly complex problems—it is rewarding and fulfilling to see that expertise play out in the health care market with HVH by meaningfully improving the lives of patients that would otherwise be undiagnosed.”

About HVH Precision Analytics
HVH Precision Analytics (HVH) is a leading provider of advanced analytics and services utilizing real-world data for actionable insights. By leveraging large amounts of disparate health data, HVH collects, aggregates, analyzes and creates a longitudinal patient journey enabling actionable insights, powered by superior predictive analytics to support our clients’ precise requirements. ​HVH is transforming the way biopharma companies identify patients and connect with providers anywhere and at any point in the product lifecycle. For more information about HVH, visit

About Havas Health & You
Havas Health & You unites Havas Life, Health4Brands (H4B), Lynx, Havas Life PR and Havas Health Plus, all wholly owned health and communications networks, with the consumer health businesses and practices of Havas Creative Group. Its customer-centric approach has the talent, tenacity and technology that health-and-wellness companies, brands and people need to thrive in today’s world. For more information, go to

About Perspecta
At Perspecta (NYSE: PRSP), we question, we seek and we solve. Perspecta brings a diverse set of capabilities to our U.S. government customers in defense, intelligence, civilian, health care and state and local markets. Our 260+ issued, licensed and pending patents are more than just pieces of paper, they tell the story of our innovation. With offerings in mission services, digital transformation and enterprise operations, our team of 14,000 engineers, analysts, investigators and architects work tirelessly to not only execute the mission, but build and support the backbone that enables it. Perspecta was formed to take on big challenges. We are an engine for growth and success and we enable our customers to build a better nation. For more information about Perspecta, visit